Login to Your Account

Financings Roundup

Radius Health Gets $43M to Push Osteo Injection, Patch

By Randy Osborne
Staff Writer

Thursday, April 25, 2013

Radius Health Inc.'s new equity cash of $43 million will go toward further work with its anabolic bone builder BA058, in Phase III trials as an injectable therapy and Phase II as a "short-wear" patch.

Cash on hand with the latest financing "should take us neatly through the patch data [due in September], and then we'll make a decision on what the next steps are," said Michael Wyzga, president and CEO of Cambridge, Mass.-based Radius. Phase III data with the subcutaneous version will be available "on the back half of 2014," he said.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription